@gadrinium
>Nタンパク/N抗体の話はみんな認識
どうせin vitroだろpgrって反応には、ならなかったですか?
私の目から見れば、
in vivo (SARS-1 in mouse)
in vivo (covid-19当初からの観察)
in the world (2021年7月インドネシア)
in vitro (私のSciRep)
in the world(中国の白肺)
in vivo 再感染←今ココ
Reinfection with COVID-19 led to a greater risk of developing asthma, COPD, lung diseases, and lung cancer compared to those with a single infection.
Additionally, most risks of respiratory outcomes were increased before the availability of COVID-19 vaccination. 3/
Chronic inflammation, neutrophil activity, and autoreactivity splits long COVID
We may have 2 subtypes of
#LongCovid
/ PASC!
➡️"The overwhelming disease burden attributable to PASC worldwide6 demands that serious attention must be paid both to its accurate diagnosis as well as
Our paper on persistent SARS-CoV-2 infections (PIs) is now published in
@Nature
!
Some key findings:
- PIs are much more common than we thought
- PIs are associated with higher odds of long COVID
- Reinfections with genetically similar viruses are rare
中国はゼロコロナ政策撤廃時に、公式には8万人しか死者数を数えていないが、少なくとも187万人の死者が出たと考えられている。
不活化ワクチンは効果が弱いどころか、抗N抗体によるADE of cytokine productionによる重症化が懸念される中で、シノバック・シノファームは成績が良いと騙されていた人は
As a clinician, I've seen young patients die of sepsis from atypical organisms with lymphopoenia weeks after acute COVID. I've seen deaths from TB and endocarditis. I've treated multidermatomal shingles. I routinely look out for post-COVID lymphopoenia 🧵
Our serology paper is out now. It demonstrates the potential benefit of having COVID-19 vaccination.
BA.2 breakthrough infections in vaccinated individuals elicited higher levels of BA.4 or BA.5 neutralizing antibody compared to BA.2 infections in vaccine-naïve individuals. /1
long COVIDの有意な予測因子となった。
long COVIDがあるものは中央値6個の症状あり。多い症状は倦怠感70.6%、集中困難59.6%。
調査の前月に当該症状により38.2%は受診を、1.6%は入院を要した。
元々就労/就学中のlong COVID-19患者の17.9%は仕事や学校を辞めるか休むようになった。
→
Relationship between SARS-CoV-2 viral dynamics during acute infection & development of
#LongCOVID
:
A NEW study finds that the longer the time from peak viral load to viral RNA clearance during acute COVID-19, the higher risk of developing
#LongCOVID
. 1/